Last update 28 Mar 2026

ET019003-T Cells

Overview

Basic Info

Drug Type
CAR-T
Synonyms
Anti-CD19 ARTEMIS™ Therapy, Anti-CD19 chimeric antigen receptor T cell therapy (Eureka Therapeutics), Anti-CD19 immunotherapy (Eureka Therapeutics)
+ [3]
Target
CD19
Action
modulators
Mechanism
CD19 modulators(B-lymphocyte antigen CD19 modulators)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
CD19 positive B-Cell Lymphoma
Originator Organization
Eureka(Beijing) Biotechnology Co., Ltd.Eureka(Beijing) Biotechnology Co., Ltd.
Active Organization-
Inactive Organization
Eureka(Beijing) Biotechnology Co., Ltd.Eureka(Beijing) Biotechnology Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ET019003-T Cells
NCT04014894
/ Unknown statusPhase 1IIT
Safety and Efficiency Study of ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma
100 Clinical Results associated with ET019003-T Cells
Login to view more data
100 Translational Medicine associated with ET019003-T Cells
Login to view more data
100 Patents (Medical) associated with ET019003-T Cells
Login to view more data
100 Deals associated with ET019003-T Cells
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD19 positive B-Cell LymphomaPhase 1
China
Eureka(Beijing) Biotechnology Co., Ltd.Eureka(Beijing) Biotechnology Co., Ltd.
12 Jun 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT04014894 (ASH 12021 | ASH 22021)
ManualManual
Phase 1
Diffuse large B-cell lymphoma recurrent
CD19 Positive
8
fludarabine+Cyclophosphamide
sidlwcxeya(fzldppshzd) = ldwylierzo aeteofqeof (kwnjrgnutc )
View more
Positive
05 Nov 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free